These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16728272)

  • 1. Epstein-Barr virus and the germinal center B cells.
    Khan G
    Exp Hematol; 2006 Jun; 34(6):695-6. PubMed ID: 16728272
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus in the germinal centres of adenopathies affected by classic Hodgkin lymphoma.
    Martín P; Gomez-Lozano N; Montes S; Salas C; Provencio M; Bellas C
    Histopathology; 2011 Aug; 59(2):349-52. PubMed ID: 21884218
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell transformation induced by Epstein-Barr virus--living dangerously.
    Rowe M
    Semin Cancer Biol; 2001 Dec; 11(6):403-5. PubMed ID: 11669601
    [No Abstract]   [Full Text] [Related]  

  • 4. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of the intersection of Epstein-Barr virus with germinal center.
    Martín P; Coronado MJ; Bellas C
    APMIS; 2012 Mar; 120(3):253-4. PubMed ID: 22339684
    [No Abstract]   [Full Text] [Related]  

  • 6. HHV-8- and EBV-positive germinotropic lymphoproliferative disorder.
    Zanelli M; Fraternali Orcioni G; Zizzo M; De Marco L; Martino G; Cerrone G; Cabras AD; Ascani S
    Ann Hematol; 2019 Oct; 98(10):2439-2441. PubMed ID: 31377818
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
    Price AM; Luftig MA
    PLoS Pathog; 2015 Mar; 11(3):e1004656. PubMed ID: 25790223
    [No Abstract]   [Full Text] [Related]  

  • 9. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres and a high content of EBV-infected large B-cells carrying IgH chain gene monoclonal rearrangement.
    Luzzatto F; Pruneri G; Benini E; Manzotti M; Laszlo D; Martinelli G; Viale G
    Histopathology; 2005 Apr; 46(4):464-6. PubMed ID: 15810960
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells.
    Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D
    J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
    Ng SB; Khoury JD
    Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Epstein-Barr virus glycoprotein complexes.
    Hutt-Fletcher LM; Lake CM
    Curr Top Microbiol Immunol; 2001; 258():51-64. PubMed ID: 11443867
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation of lymphoblastoid cell lines (LCLs).
    Frisan T; Levitsky V; Masucci M
    Methods Mol Biol; 2001; 174():125-7. PubMed ID: 11357634
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality.
    Thorley-Lawson DA; Duca KA; Shapiro M
    Trends Immunol; 2008 Apr; 29(4):195-201. PubMed ID: 18328785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant role of macrophages in human cancers associated with Epstein-Barr virus (Review).
    Shimakage M
    Oncol Rep; 2014 Nov; 32(5):1763-71. PubMed ID: 25224510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of the cell cycle by the Epstein-Barr virus.
    O'Nions J; Allday MJ
    Adv Cancer Res; 2004; 92():119-86. PubMed ID: 15530559
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-barr virus-induced expression of a novel human vault RNA.
    Nandy C; Mrázek J; Stoiber H; Grässer FA; Hüttenhofer A; Polacek N
    J Mol Biol; 2009 May; 388(4):776-84. PubMed ID: 19298825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.